Literature DB >> 16110250

Role of inflammation in pancreatic carcinogenesis and the implications for future therapy.

G Garcea1, A R Dennison, W P Steward, D P Berry.   

Abstract

BACKGROUND: The link between inflammation and pancreatic cancer has been observed for a number of gastrointestinal neoplasms. This review examines the role of inflammation in pancreatic carcinogenesis and how it can be utilised to develop new therapies against pancreatic cancer.
METHODS: A literature review of Pubmed, Medline and Web of Science databases was undertaken using the key words, pancreatic cancer, inflammation, inducible nitric oxide, interleukins, pro-inflammatory cytokines, cyclooxygenase-2, NF-kappa B, reactive oxygen species, DNA adducts, lipoxygenases, chemoprevention.
RESULTS: Epidemiological evidence and molecular studies both in vitro and in vivo all support the hypothesis that inflammation plays an important in the initiation and progression of pancreatic tumours.
CONCLUSION: Sustained damage caused by chronic inflammation may precede the onset of frank malignancy by a significant interval. As such, suppression of inflammatory changes and oxidative damage, may help delay or even prevent the inception of pancreatic neoplasia. Copyright 2005 S. Karger AG, Basel and IAP.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16110250     DOI: 10.1159/000087493

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  56 in total

1.  Micronuclei levels in peripheral blood lymphocytes as a potential biomarker for pancreatic cancer risk.

Authors:  Ping Chang; Yanan Li; Donghui Li
Journal:  Carcinogenesis       Date:  2010-11-19       Impact factor: 4.944

2.  Expression of the CXCR6 on polymorphonuclear neutrophils in pancreatic carcinoma and in acute, localized bacterial infections.

Authors:  M M Gaida; F Günther; C Wagner; H Friess; N A Giese; J Schmidt; G M Hänsch; M N Wente
Journal:  Clin Exp Immunol       Date:  2008-09-05       Impact factor: 4.330

3.  Prediagnostic adiponectin concentrations and pancreatic cancer risk in male smokers.

Authors:  Rachael Z Stolzenberg-Solomon; Stephanie Weinstein; Michael Pollak; Yuzhen Tao; Philip R Taylor; Jarmo Virtamo; Demetrius Albanes
Journal:  Am J Epidemiol       Date:  2008-09-18       Impact factor: 4.897

4.  Macrophage migration inhibitory factor induces epithelial to mesenchymal transition, enhances tumor aggressiveness and predicts clinical outcome in resected pancreatic ductal adenocarcinoma.

Authors:  Naotake Funamizu; Chaoxin Hu; Curtis Lacy; Aaron Schetter; Geng Zhang; Peijun He; Jochen Gaedcke; Michael B Ghadimi; Thomas Ried; Harris G Yfantis; Dong H Lee; Jeffrey Subleski; Tim Chan; Jonathan M Weiss; Timothy C Back; Katsuhiko Yanaga; Nader Hanna; H Richard Alexander; Anirban Maitra; S Perwez Hussain
Journal:  Int J Cancer       Date:  2013-02-15       Impact factor: 7.396

Review 5.  Connection between inflammation and carcinogenesis in gastrointestinal tract: focus on TGF-beta signaling.

Authors:  Suntaek Hong; Ho-Jae Lee; Seong Jin Kim; Ki-Baik Hahm
Journal:  World J Gastroenterol       Date:  2010-05-07       Impact factor: 5.742

Review 6.  Hedgehog signaling pathway as a new therapeutic target in pancreatic cancer.

Authors:  Hideya Onishi; Mitsuo Katano
Journal:  World J Gastroenterol       Date:  2014-03-07       Impact factor: 5.742

Review 7.  Does the vaginal microbiota play a role in the development of cervical cancer?

Authors:  Maria Kyrgiou; Anita Mitra; Anna-Barbara Moscicki
Journal:  Transl Res       Date:  2016-07-15       Impact factor: 7.012

8.  Polymorphisms in tumour necrosis factor alpha (TNFalpha) gene in patients with acute pancreatitis.

Authors:  Gül Ozhan; Hakan T Yanar; Cemalettin Ertekin; Buket Alpertunga
Journal:  Mediators Inflamm       Date:  2010-04-14       Impact factor: 4.711

9.  ABO blood group and the risk of pancreatic cancer.

Authors:  Brian M Wolpin; Andrew T Chan; Patricia Hartge; Stephen J Chanock; Peter Kraft; David J Hunter; Edward L Giovannucci; Charles S Fuchs
Journal:  J Natl Cancer Inst       Date:  2009-03-10       Impact factor: 13.506

10.  ABO blood type, long-standing diabetes, and the risk of pancreatic cancer.

Authors:  Naoto Egawa; Yingsong Lin; Taku Tabata; Sawako Kuruma; Seiichi Hara; Ken Kubota; Terumi Kamisawa
Journal:  World J Gastroenterol       Date:  2013-04-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.